| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.691 | 0.01 | 0.691 | Thyroid hormone antagonist | 0.317 0.085 DBMET01171 0.637 0.015 DBMET01769 | ||
| 0.68 | 0.011 | 0.68 | Thyroid hormone beta antagonist | 0.278 0.1 DBMET01171 0.619 0.016 DBMET01769 | ||
| 0.65 | 0.001 | 0.65 | Electrolyte absorption antagonist | 0.467 0.002 DBMET01171 0.529 0.002 DBMET01769 0.101 0.057 DBMET00163 | ||
| 0.522 | 0.007 | 0.522 | Diuretic | 0.351 0.016 DBMET01171 0.512 0.007 DBMET01769 | ||
| 0.524 | 0.016 | 0.524 | Lipoxygenase inhibitor | 0.511 0.017 DBMET01171 0.346 0.052 DBMET01769 0.423 0.032 DBMET00163 | ||
| 0.521 | 0.037 | 0.521 | Prostaglandin dehydrogenase inhibitor | 0.321 0.093 DBMET01171 0.404 0.066 DBMET01769 | ||
| 0.493 | 0.02 | 0.493 | Interleukin antagonist | 0.457 0.024 DBMET01171 0.481 0.021 DBMET01769 0.357 0.038 DBMET00163 | ||
| 0.466 | 0.005 | 0.466 | Interleukin 1 antagonist | 0.444 0.005 DBMET01171 0.464 0.005 DBMET01769 0.31 0.01 DBMET00163 | ||
| 0.479 | 0.045 | 0.479 | 15-Lipoxygenase inhibitor | 0.277 0.145 DBMET01769 | ||
| 0.442 | 0.055 | 0.442 | 5 Hydroxytryptamine release inhibitor | 0.315 0.149 DBMET01769 | ||
| 0.437 | 0.073 | 0.437 | Cyclophilin D inhibitor | 0.408 0.086 DBMET01171 0.382 0.101 DBMET01769 0.334 0.135 DBMET00163 | ||
| 0.368 | 0.018 | 0.368 | Dual specificity phosphatase 3 inhibitor | 0.234 0.046 DBMET01171 0.247 0.041 DBMET01769 | ||
| 0.358 | 0.019 | 0.568 | Non-steroidal antiinflammatory agent | 0.234 0.05 DBMET01171 0.234 0.05 DBMET01769 0.568 0.005 DBMET00163 | DBMET00163 | |
| 0.437 | 0.105 | 0.437 | DNA polymerase beta inhibitor | |||
| 0.321 | 0.002 | 0.321 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.294 0.003 DBMET01171 0.105 0.005 DBMET01769 0.301 0.003 DBMET00163 | ||
| 0.322 | 0.005 | 0.322 | Uric acid excretion stimulant | 0.264 0.006 DBMET01171 0.313 0.005 DBMET01769 0.111 0.044 DBMET00163 | ||
| 0.408 | 0.112 | 0.408 | DNA directed DNA polymerase inhibitor | |||
| 0.311 | 0.027 | 0.311 | Dual specificity phosphatase inhibitor | 0.177 0.069 DBMET01171 0.188 0.062 DBMET01769 | ||
| 0.341 | 0.065 | 0.341 | Streptokinase A inhibitor | 0.162 0.161 DBMET01769 | ||
| 0.313 | 0.049 | 0.672 | Platelet antagonist | 0.672 0.005 DBMET01171 0.334 0.042 DBMET01769 | DBMET01171 | |
| 0.328 | 0.075 | 0.41 | Cholesterol antagonist | 0.234 0.137 DBMET01769 0.41 0.047 DBMET00163 | DBMET00163 | |
| 0.338 | 0.088 | 0.452 | Toll-Like receptor 7 agonist | 0.452 0.043 DBMET01171 0.303 0.108 DBMET01769 | DBMET01171 | |
| 0.327 | 0.095 | 0.441 | Toll-Like receptor agonist | 0.441 0.046 DBMET01171 0.292 0.116 DBMET01769 | DBMET01171 | |
| 0.251 | 0.026 | 0.452 | Cyclooxygenase inhibitor | 0.318 0.015 DBMET01171 0.185 0.048 DBMET01769 0.452 0.005 DBMET00163 | DBMET00163 | |
| 0.229 | 0.012 | 0.265 | Arachidonic acid antagonist | 0.236 0.009 DBMET01171 0.213 0.022 DBMET01769 0.265 0.004 DBMET00163 | DBMET00163 | |
| 0.246 | 0.032 | 0.246 | Protein-tyrosine phosphatase inhibitor | 0.153 0.076 DBMET01171 0.217 0.041 DBMET01769 | ||
| 0.222 | 0.015 | 0.378 | Interleukin 1b antagonist | 0.227 0.014 DBMET01171 0.378 0.005 DBMET01769 | DBMET01769 | |
| 0.27 | 0.065 | 0.303 | Hypoglycemic | 0.303 0.052 DBMET01171 0.211 0.102 DBMET01769 0.263 0.069 DBMET00163 | DBMET01171 | |
| 0.228 | 0.026 | 0.61 | Cyclooxygenase 1 inhibitor | 0.182 0.042 DBMET01171 0.152 0.055 DBMET01769 0.61 0.004 DBMET00163 | DBMET00163 | |
| 0.285 | 0.086 | 0.285 | Caspase 3 stimulant | 0.233 0.128 DBMET01769 | ||
| 0.203 | 0.005 | 0.203 | Glutathione S-transferase inhibitor | 0.133 0.017 DBMET01171 0.194 0.006 DBMET01769 | ||
| 0.334 | 0.138 | 0.334 | Transcription factor inhibitor | |||
| 0.274 | 0.08 | 0.274 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.218 | 0.034 | 0.218 | Phospholipase A2 inhibitor | 0.211 0.037 DBMET01171 0.213 0.036 DBMET01769 0.137 0.09 DBMET00163 | ||
| 0.243 | 0.07 | 0.251 | Hypolipemic | 0.193 0.099 DBMET01171 0.251 0.067 DBMET01769 0.249 0.068 DBMET00163 | DBMET01769 | |
| 0.179 | 0.01 | 0.179 | Macrophage migration inhibitory factor inhibitor | 0.125 0.024 DBMET01769 | ||
| 0.278 | 0.116 | 0.278 | Thioredoxin glutathione reductase inhibitor | |||
| 0.229 | 0.068 | 0.229 | Pyruvate kinase inhibitor | |||
| 0.172 | 0.011 | 0.172 | Interleukin 2 antagonist | 0.134 0.029 DBMET01171 0.148 0.019 DBMET01769 | ||
| 0.204 | 0.046 | 0.214 | Succinate dehydrogenase inhibitor | 0.204 0.046 DBMET01171 0.214 0.039 DBMET01769 0.197 0.051 DBMET00163 | DBMET01769 | |
| 0.267 | 0.115 | 0.348 | Vasodilator, peripheral | 0.348 0.074 DBMET01769 | DBMET01769 | |
| 0.213 | 0.061 | 0.213 | Insulin sensitizer | 0.181 0.095 DBMET01769 0.16 0.119 DBMET00163 | ||
| 0.173 | 0.027 | 0.189 | Expectorant | 0.106 0.063 DBMET01171 0.161 0.031 DBMET01769 0.189 0.023 DBMET00163 | DBMET00163 | |
| 0.216 | 0.072 | 0.216 | Anticonvulsant | 0.18 0.099 DBMET01769 | ||
| 0.165 | 0.022 | 0.165 | Sphingosine 1-phosphate receptor 4 antagonist | 0.158 0.027 DBMET01769 | ||
| 0.164 | 0.025 | 0.213 | Mucolytic | 0.11 0.064 DBMET01171 0.156 0.029 DBMET01769 0.213 0.011 DBMET00163 | DBMET00163 | |
| 0.145 | 0.011 | 0.145 | Prostaglandin antagonist | 0.116 0.014 DBMET01171 0.134 0.012 DBMET01769 | ||
| 0.312 | 0.181 | 0.312 | Caspase 9 stimulant | 0.284 0.212 DBMET01171 0.291 0.204 DBMET01769 0.309 0.184 DBMET00163 | ||
| 0.138 | 0.011 | 0.138 | Prostaglandin EP2 antagonist | 0.059 0.042 DBMET01171 0.116 0.015 DBMET01769 | ||
| 0.131 | 0.008 | 0.131 | Peroxisome proliferator-activated receptor gamma antagonist | 0.093 0.02 DBMET01171 0.091 0.022 DBMET01769 0.104 0.014 DBMET00163 | ||
| 0.194 | 0.072 | 0.194 | DNA methyltransferase I inhibitor | |||
| 0.128 | 0.007 | 0.128 | NMDA receptor glycine site agonist | 0.077 0.03 DBMET01171 0.091 0.021 DBMET01769 | ||
| 0.154 | 0.044 | 0.154 | Protein-tyrosine phosphatase 1B inhibitor | 0.092 0.087 DBMET01171 0.153 0.044 DBMET01769 | ||
| 0.193 | 0.084 | 0.193 | DNA methylase inhibitor | |||
| 0.112 | 0.005 | 0.112 | Peroxisome proliferator-activated receptor delta agonist | 0.051 0.012 DBMET01171 0.088 0.007 DBMET01769 0.037 0.019 DBMET00163 | ||
| 0.176 | 0.07 | 0.176 | Mcl-1 antagonist | 0.126 0.118 DBMET01171 0.133 0.108 DBMET01769 | ||
| 0.127 | 0.023 | 0.127 | Interleukin 12 antagonist | 0.098 0.057 DBMET01171 0.117 0.032 DBMET01769 | ||
| 0.122 | 0.019 | 0.122 | Peroxisome proliferator-activated receptor gamma agonist | 0.103 0.026 DBMET01171 0.097 0.029 DBMET01769 0.09 0.034 DBMET00163 | ||
| 0.15 | 0.048 | 0.15 | Aldehyde dehydrogenase inhibitor | 0.14 0.054 DBMET01769 | ||
| 0.168 | 0.069 | 0.339 | Thrombolytic | 0.339 0.018 DBMET01171 0.145 0.086 DBMET01769 0.236 0.037 DBMET00163 | DBMET01171 | |
| 0.112 | 0.015 | 0.16 | Aldose reductase inhibitor | 0.16 0.01 DBMET01171 0.106 0.017 DBMET01769 0.056 0.034 DBMET00163 | DBMET01171 | |
| 0.119 | 0.022 | 0.121 | Glutamate release inhibitor | 0.09 0.061 DBMET01171 0.087 0.069 DBMET01769 0.121 0.021 DBMET00163 | DBMET00163 | |
| 0.224 | 0.127 | 0.224 | 12-Lipoxygenase inhibitor | |||
| 0.1 | 0.005 | 0.1 | Prostaglandin agonist | 0.052 0.01 DBMET01171 0.053 0.009 DBMET01769 | ||
| 0.11 | 0.016 | 0.11 | NMDA receptor agonist | 0.06 0.048 DBMET01171 0.074 0.033 DBMET01769 | ||
| 0.093 | 0.005 | 0.093 | Prostacyclin antagonist | 0.077 0.006 DBMET01171 0.09 0.005 DBMET01769 | ||
| 0.098 | 0.01 | 0.157 | Plasminogen activator inhibitor antagonist | 0.157 0.005 DBMET01171 0.064 0.021 DBMET01769 | DBMET01171 | |
| 0.128 | 0.042 | 0.128 | Estrogen antagonist | 0.119 0.056 DBMET01171 0.124 0.047 DBMET01769 0.103 0.091 DBMET00163 | ||
| 0.089 | 0.004 | 0.089 | Prostaglandin E2 agonist | 0.038 0.008 DBMET01171 0.038 0.008 DBMET01769 | ||
| 0.119 | 0.036 | 0.119 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.088 | 0.009 | 0.097 | Thromboxane synthase inhibitor | 0.097 0.007 DBMET01171 0.082 0.011 DBMET01769 0.067 0.02 DBMET00163 | DBMET01171 | |
| 0.095 | 0.018 | 0.095 | CDC25B inhibitor | 0.067 0.041 DBMET01171 0.076 0.032 DBMET01769 | ||
| 0.128 | 0.053 | 0.135 | Microtubule formation inhibitor | 0.118 0.063 DBMET01769 0.135 0.047 DBMET00163 | DBMET00163 | |
| 0.078 | 0.003 | 0.078 | Integrin alpha1beta1 antagonist | 0.057 0.005 DBMET01171 0.065 0.004 DBMET01769 | ||
| 0.124 | 0.055 | 0.124 | Cystathionine beta-synthase inhibitor | 0.124 0.055 DBMET01171 0.115 0.062 DBMET01769 | ||
| 0.231 | 0.163 | 0.231 | Calpain 2 inhibitor | |||
| 0.096 | 0.029 | 0.18 | Leukotriene synthesis inhibitor | 0.18 0.006 DBMET01171 0.101 0.026 DBMET01769 | DBMET01171 | |
| 0.133 | 0.068 | 0.281 | Cyclooxygenase 2 inhibitor | 0.167 0.043 DBMET01171 0.111 0.09 DBMET01769 0.281 0.016 DBMET00163 | DBMET00163 | |
| 0.219 | 0.155 | 0.461 | Antithrombotic | 0.461 0.035 DBMET01171 0.285 0.099 DBMET01769 0.309 0.082 DBMET00163 | DBMET01171 | |
| 0.067 | 0.007 | 0.067 | Peroxisome proliferator-activated receptor delta antagonist | 0.046 0.011 DBMET01171 0.055 0.009 DBMET01769 | ||
| 0.113 | 0.053 | 0.113 | DOPA decarboxylase inhibitor | 0.1 0.076 DBMET01769 0.107 0.063 DBMET00163 | ||
| 0.141 | 0.082 | 0.141 | Cytidine deaminase inhibitor | |||
| 0.248 | 0.189 | 0.248 | Alpha-glucosidase inhibitor | |||
| 0.061 | 0.005 | 0.061 | Prostaglandin D2 antagonist | 0.031 0.011 DBMET01171 0.06 0.005 DBMET01769 | ||
| 0.075 | 0.02 | 0.075 | Peroxisome proliferator-activated receptor alpha agonist | 0.047 0.034 DBMET01769 0.064 0.024 DBMET00163 | ||
| 0.058 | 0.008 | 0.058 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.047 0.018 DBMET01769 | ||
| 0.067 | 0.018 | 0.067 | Prolyl endopeptidase inhibitor | 0.057 0.028 DBMET01769 | ||
| 0.08 | 0.032 | 0.081 | Leukotriene antagonist | 0.08 0.032 DBMET01171 0.081 0.031 DBMET01769 0.074 0.036 DBMET00163 | DBMET01769 | |
| 0.049 | 0.006 | 0.049 | Prostaglandin EP2 agonist | 0.024 0.015 DBMET01171 0.045 0.007 DBMET01769 | ||
| 0.05 | 0.008 | 0.053 | Prostaglandin D2 agonist | 0.046 0.009 DBMET01171 0.053 0.007 DBMET01769 | DBMET01769 | |
| 0.083 | 0.043 | 0.083 | Estrogen receptor alpha antagonist | 0.076 0.055 DBMET01769 | ||
| 0.099 | 0.062 | 0.099 | Nitric-oxide synthase inhibitor | |||
| 0.093 | 0.056 | 0.125 | Triose-phosphate isomerase inhibitor | 0.093 0.056 DBMET01171 0.107 0.041 DBMET01769 0.125 0.03 DBMET00163 | DBMET00163 | |
| 0.098 | 0.061 | 0.098 | Xanthine oxidase inhibitor | 0.088 0.075 DBMET01171 0.093 0.067 DBMET01769 | ||
| 0.042 | 0.005 | 0.042 | Prostaglandin EP4 agonist | 0.018 0.009 DBMET01171 | ||
| 0.062 | 0.026 | 0.062 | Leukotriene B4 antagonist | 0.052 0.039 DBMET01171 0.054 0.036 DBMET01769 | ||
| 0.143 | 0.109 | 0.355 | Amyloid beta precursor protein antagonist | 0.355 0.009 DBMET00163 | DBMET00163 | |
| 0.135 | 0.101 | 0.137 | Interferon gamma antagonist | 0.137 0.097 DBMET00163 | DBMET00163 | |
| 0.144 | 0.112 | 0.144 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.058 | 0.026 | 0.058 | Glucose-6-phosphate translocase inhibitor | |||
| 0.049 | 0.02 | 0.049 | NMDA receptor subunit 3A antagonist | |||
| 0.107 | 0.078 | 0.107 | Cell adhesion inhibitor | |||
| 0.057 | 0.028 | 0.057 | Beta 2 adrenoreceptor antagonist | |||
| 0.072 | 0.043 | 0.072 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.069 | 0.04 | 0.069 | Beta adrenoreceptor antagonist | 0.061 0.054 DBMET01769 | ||
| 0.097 | 0.07 | 0.097 | Estrogen receptor beta antagonist | |||
| 0.097 | 0.07 | 0.097 | Folate antagonist | |||
| 0.054 | 0.028 | 0.054 | Glycine transporter inhibitor | |||
| 0.043 | 0.018 | 0.043 | VCAM-1 antagonist | 0.037 0.036 DBMET01769 | ||
| 0.043 | 0.018 | 0.043 | VCAM antagonist | 0.037 0.036 DBMET01769 | ||
| 0.044 | 0.02 | 0.044 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.119 | 0.095 | 0.119 | CDC-like kinase 1 inhibitor | |||
| 0.029 | 0.007 | 0.029 | ICAM 1 antagonist | |||
| 0.034 | 0.012 | 0.034 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.039 | 0.018 | 0.039 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.033 0.025 DBMET01769 | ||
| 0.12 | 0.1 | 0.122 | Mannose-6-phosphate isomerase inhibitor | 0.122 0.098 DBMET01769 0.116 0.108 DBMET00163 | DBMET01769 | |
| 0.037 | 0.019 | 0.037 | Glutamate (mGluR4) agonist | |||
| 0.122 | 0.105 | 0.122 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.212 | 0.196 | 0.408 | Calcium channel activator | 0.292 0.1 DBMET01171 0.271 0.122 DBMET01769 0.408 0.022 DBMET00163 | DBMET00163 | |
| 0.266 | 0.249 | 0.782 | Antiinflammatory | 0.782 0.018 DBMET00163 | DBMET00163 | |
| 0.079 | 0.063 | 0.079 | Inducible nitric-oxide synthase inhibitor | |||
| 0.022 | 0.007 | 0.023 | Thyroid hormone alpha antagonist | 0.02 0.008 DBMET01171 0.023 0.006 DBMET01769 | DBMET01769 | |
| 0.023 | 0.009 | 0.027 | Retinoid X beta receptor antagonist | 0.021 0.014 DBMET01769 0.027 0.005 DBMET00163 | DBMET00163 | |
| 0.029 | 0.015 | 0.03 | Retinoid X gamma receptor antagonist | 0.027 0.019 DBMET01769 0.03 0.013 DBMET00163 | DBMET00163 | |
| 0.122 | 0.108 | 0.317 | Insulin secretagoues | 0.317 0.011 DBMET01171 | DBMET01171 | |
| 0.022 | 0.008 | 0.022 | G-protein-coupled receptor 120 agonist | 0.016 0.013 DBMET01171 0.02 0.009 DBMET01769 | ||
| 0.151 | 0.138 | 0.268 | Aldehyde oxidase inhibitor | 0.151 0.138 DBMET01171 0.261 0.078 DBMET01769 0.268 0.076 DBMET00163 | DBMET00163 | |
| 0.038 | 0.026 | 0.049 | Retinoid X receptor antagonist | 0.049 0.013 DBMET00163 | DBMET00163 | |
| 0.086 | 0.074 | 0.169 | 5-Lipoxygenase inhibitor | 0.09 0.072 DBMET01171 0.169 0.032 DBMET00163 | DBMET00163 | |
| 0.055 | 0.044 | 0.055 | Leukotriene C antagonist | 0.053 0.05 DBMET01171 | ||
| 0.052 | 0.04 | 0.052 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.052 0.04 DBMET01171 0.051 0.042 DBMET01769 | ||
| 0.02 | 0.008 | 0.02 | Prostacyclin agonist | 0.019 0.009 DBMET01171 0.02 0.009 DBMET01769 | ||
| 0.05 | 0.039 | 0.055 | Aconitate hydratase inhibitor | 0.05 0.039 DBMET01171 0.05 0.039 DBMET01769 0.055 0.031 DBMET00163 | DBMET00163 | |
| 0.019 | 0.008 | 0.019 | Thyroid hormone alpha agonist | 0.019 0.008 DBMET01171 0.019 0.008 DBMET01769 | ||
| 0.105 | 0.094 | 0.219 | Alpha-N-acetylglucosaminidase inhibitor | 0.105 0.094 DBMET01171 0.105 0.094 DBMET01769 0.219 0.029 DBMET00163 | DBMET00163 | |
| 0.106 | 0.095 | 0.106 | Tubulin antagonist | |||
| 0.052 | 0.042 | 0.052 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.077 | 0.067 | 0.077 | Caspase 7 inhibitor | |||
| 0.034 | 0.024 | 0.043 | Retinoid X alpha receptor antagonist | 0.043 0.012 DBMET00163 | DBMET00163 | |
| 0.153 | 0.143 | 0.153 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.087 | 0.078 | 0.087 | Alpha 2d adrenoreceptor antagonist | |||
| 0.034 | 0.025 | 0.034 | Purinergic P2X3 antagonist | |||
| 0.109 | 0.101 | 0.109 | Antibacterial (Helicobacter pylori) | |||
| 0.059 | 0.052 | 0.059 | Beta 2 adrenoreceptor agonist | |||
| 0.194 | 0.187 | 0.206 | Vasodilator, coronary | 0.206 0.176 DBMET01769 0.199 0.183 DBMET00163 | DBMET01769 | |
| 0.064 | 0.059 | 0.068 | Exportin-1 inhibitor | 0.068 0.047 DBMET01769 | DBMET01769 | |
| 0.015 | 0.01 | 0.016 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.015 0.01 DBMET01171 0.016 0.009 DBMET01769 | DBMET01769 | |
| 0.076 | 0.071 | 0.076 | NMDA receptor antagonist | |||
| 0.039 | 0.035 | 0.049 | Glutamate (mGluR group III) agonist | 0.049 0.024 DBMET01769 | DBMET01769 | |
| 0.187 | 0.183 | 0.316 | Transcription factor NF kappa B inhibitor | 0.316 0.087 DBMET00163 | DBMET00163 | |
| 0.138 | 0.136 | 0.138 | Neurotensin receptor agonist | |||
| 0.129 | 0.127 | 0.269 | Interleukin 6 antagonist | 0.196 0.043 DBMET01769 0.269 0.019 DBMET00163 | DBMET00163 | |
| 0.046 | 0.045 | 0.046 | CD45 antagonist | |||
| 0.026 | 0.025 | 0.026 | Prostaglandin EP3 antagonist | |||
| 0.102 | 0.104 | 0.215 | Bone formation stimulant | 0.215 0.032 DBMET01171 | DBMET01171 | |
| 0.014 | 0.019 | 0.02 | Peroxisome proliferator-activated receptor alpha antagonist | 0.02 0.015 DBMET00163 | DBMET00163 | |
| 0.043 | 0.049 | 0.076 | Thromboxane antagonist | 0.063 0.03 DBMET01171 0.076 0.023 DBMET01769 | DBMET01769 | |
| 0.012 | 0.02 | 0.065 | Free fatty acid receptor 1 agonist | 0.065 0.004 DBMET01171 | DBMET01171 | |
| 0.027 | 0.038 | 0.041 | Carnitine palmitoyltransferase inhibitor | 0.041 0.015 DBMET01769 | DBMET01769 | |
| 0.076 | 0.088 | 0.085 | ATPase (Vacuolar H+) inhibitor | 0.085 0.066 DBMET00163 | DBMET00163 | |
| 0.034 | 0.052 | 0.061 | Thromboxane A2 antagonist | 0.056 0.031 DBMET01171 0.061 0.028 DBMET01769 | DBMET01769 | |
| 0.038 | 0.057 | 0.078 | Carnitine palmitoyltransferase 1B inhibitor | 0.078 0.008 DBMET01171 0.047 0.034 DBMET01769 | DBMET01171 | |
| 0.026 | 0.044 | 0.04 | Carnitine palmitoyltransferase 1 inhibitor | 0.04 0.016 DBMET01769 | DBMET01769 | |
| 0.038 | 0.059 | 0.05 | Glucose-6-phosphate isomerase inhibitor | 0.05 0.03 DBMET00163 | DBMET00163 | |
| 0.012 | 0.039 | 0.022 | Prostaglandin H2 antagonist | 0.022 0.021 DBMET01171 | DBMET01171 | |
| 0.022 | 0.05 | 0.05 | Retinoid X alpha receptor agonist | 0.05 0.014 DBMET00163 | DBMET00163 | |
| 0.144 | 0.173 | 0.274 | Antioxidant | 0.274 0.072 DBMET00163 | DBMET00163 | |
| 0.073 | 0.104 | 0.085 | UDP-glucose 4-epimerase inhibitor | 0.085 0.081 DBMET00163 | DBMET00163 | |
| 0.045 | 0.077 | 0.082 | Phosphofructokinase-1 inhibitor | 0.082 0.04 DBMET00163 | DBMET00163 | |
| 0.124 | 0.157 | 0.153 | Ca2+-transporting ATPase inhibitor | 0.153 0.037 DBMET00163 | DBMET00163 | |
| 0.055 | 0.089 | 0.077 | Glutamate (mGluR6) antagonist | 0.077 0.028 DBMET00163 | DBMET00163 | |
| 0.068 | 0.108 | 0.087 | NADH dehydrogenase inhibitor | 0.087 0.061 DBMET00163 | DBMET00163 | |
| 0.066 | 0.112 | 0.087 | Mediator release inhibitor | 0.087 0.085 DBMET01769 | DBMET01769 | |
| 0.113 | 0.16 | 0.265 | Anesthetic general | 0.265 0.044 DBMET00163 | DBMET00163 | |
| 0.123 | 0.17 | 0.463 | Platelet aggregation inhibitor | 0.463 0.012 DBMET01171 | DBMET01171 | |
| 0.041 | 0.09 | 0.092 | DNA helicase inhibitor | 0.092 0.007 DBMET00163 | DBMET00163 | |
| 0.06 | 0.111 | 0.083 | GABA B receptor agonist | 0.083 0.036 DBMET00163 | DBMET00163 | |
| 0.065 | 0.118 | 0.104 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.104 0.05 DBMET00163 | DBMET00163 | |
| 0.014 | 0.069 | 0.041 | Retinoid X receptor agonist | 0.041 0.022 DBMET00163 | DBMET00163 | |
| 0.094 | 0.151 | 0.113 | Cell wall synthesis inhibitor | 0.113 0.111 DBMET01769 | DBMET01769 | |
| 0.024 | 0.083 | 0.039 | Liver X receptor alpha agonist | 0.039 0.031 DBMET00163 | DBMET00163 | |
| 0.013 | 0.074 | 0.028 | Carnitine palmitoyltransferase 1A inhibitor | 0.028 0.022 DBMET01171 | DBMET01171 | |
| 0.161 | 0.223 | 0.203 | Tyrosine 3 hydroxylase inhibitor | 0.203 0.13 DBMET00163 | DBMET00163 | |
| 0.074 | 0.138 | 0.138 | Adenylate kinase inhibitor | 0.138 0.031 DBMET00163 | DBMET00163 | |
| 0.012 | 0.078 | 0.036 | Leukotriene A4 hydrolase inhibitor | 0.036 0.027 DBMET01171 | DBMET01171 | |
| 0.113 | 0.192 | 0.164 | ATPase inhibitor | 0.164 0.079 DBMET00163 | DBMET00163 | |
| 0.142 | 0.221 | 0.223 | RNA-directed DNA polymerase inhibitor | 0.223 0.071 DBMET00163 | DBMET00163 | |
| 0.065 | 0.145 | 0.117 | DNA polymerase I inhibitor | 0.116 0.072 DBMET01171 0.117 0.07 DBMET00163 | DBMET00163 | |
| 0.063 | 0.144 | 0.118 | ABCA1 expression enhancer | 0.118 0.032 DBMET00163 | DBMET00163 | |
| 0.055 | 0.138 | 0.084 | Alcohol dehydrogenase inhibitor | 0.084 0.073 DBMET01769 | DBMET01769 | |
| 0.157 | 0.245 | 0.277 | Immunosuppressant | 0.236 0.16 DBMET01171 0.277 0.13 DBMET00163 | DBMET00163 | |
| 0.064 | 0.151 | 0.087 | Estrogen-related receptor beta agonist | 0.087 0.046 DBMET00163 | DBMET00163 | |
| 0.044 | 0.136 | 0.074 | Glutamate dehydrogenase inhibitor | 0.074 0.052 DBMET00163 | DBMET00163 | |
| 0.092 | 0.188 | 0.123 | Sphingosine 1-phosphate receptor 2 antagonist | 0.123 0.089 DBMET01769 | DBMET01769 | |
| 0.033 | 0.129 | 0.06 | Phenylalanine 4-hydroxylase inhibitor | 0.06 0.058 DBMET01769 | DBMET01769 | |
| 0.043 | 0.142 | 0.12 | Ornithine decarboxylase inhibitor | 0.12 0.026 DBMET00163 | DBMET00163 | |
| 0.092 | 0.193 | 0.464 | Platelet adhesion inhibitor | 0.464 0.007 DBMET01171 | DBMET01171 | |
| 0.058 | 0.165 | 0.102 | Cholesterol synthesis inhibitor | 0.102 0.085 DBMET00163 | DBMET00163 | |
| 0.058 | 0.166 | 0.116 | Bile acid receptor antagonist | 0.116 0.023 DBMET00163 | DBMET00163 | |
| 0.025 | 0.133 | 0.039 | Kainate receptor agonist | 0.039 0.035 DBMET00163 | DBMET00163 | |
| 0.157 | 0.266 | 0.242 | 5 Hydroxytryptamine uptake stimulant | 0.242 0.089 DBMET00163 | DBMET00163 | |
| 0.103 | 0.221 | 0.185 | Free radical scavenger | 0.185 0.11 DBMET00163 | DBMET00163 | |
| 0.087 | 0.207 | 0.118 | Vanilloid 1 agonist | 0.118 0.091 DBMET00163 | DBMET00163 | |
| 0.048 | 0.169 | 0.126 | HIV-1 integrase (Overall Integration) inhibitor | 0.126 0.036 DBMET00163 | DBMET00163 | |
| 0.051 | 0.176 | 0.099 | GABA C receptor agonist | 0.099 0.068 DBMET00163 | DBMET00163 | |
| 0.095 | 0.226 | 0.129 | Sphingosine 1-phosphate receptor 5 antagonist | 0.129 0.102 DBMET01769 | DBMET01769 | |
| 0.101 | 0.233 | 0.268 | Tumour necrosis factor alpha release inhibitor | 0.192 0.116 DBMET01171 0.268 0.067 DBMET01769 | DBMET01769 | |
| 0.064 | 0.199 | 0.191 | Cyclooxygenase 3 inhibitor | 0.191 0.022 DBMET00163 | DBMET00163 | |
| 0.145 | 0.283 | 0.63 | Antiobesity | 0.63 0.017 DBMET01171 | DBMET01171 | |
| 0.115 | 0.259 | 0.284 | Superoxide dismutase inhibitor | 0.284 0.056 DBMET00163 | DBMET00163 | |
| 0.026 | 0.174 | 0.083 | CXC chemokine 1 receptor antagonist | 0.083 0.008 DBMET00163 | DBMET00163 | |
| 0.067 | 0.226 | 0.126 | Anticoagulant | 0.126 0.104 DBMET01171 | DBMET01171 | |
| 0.03 | 0.193 | 0.064 | Aminopeptidase I inhibitor | 0.064 0.062 DBMET00163 | DBMET00163 | |
| 0.098 | 0.264 | 0.138 | Phospholipase C inhibitor | 0.138 0.132 DBMET00163 | DBMET00163 | |
| 0.144 | 0.313 | 0.317 | Interleukin 2 agonist | 0.317 0.063 DBMET00163 | DBMET00163 | |
| 0.038 | 0.217 | 0.12 | Glycine receptor agonist | 0.12 0.013 DBMET00163 | DBMET00163 | |
| 0.055 | 0.254 | 0.106 | Photosensitizer | 0.106 0.077 DBMET00163 | DBMET00163 | |
| 0.071 | 0.281 | 0.195 | Hepatoprotectant | 0.195 0.068 DBMET00163 | DBMET00163 | |
| 0.043 | 0.257 | 0.12 | Thioredoxin inhibitor | 0.12 0.031 DBMET00163 | DBMET00163 | |
| 0.041 | 0.279 | 0.101 | Amylase inhibitor | 0.101 0.096 DBMET00163 | DBMET00163 | |
| 0.15 | 0.392 | 0.275 | Calcium channel L-type activator | 0.275 0.18 DBMET00163 | DBMET00163 | |
| 0.052 | 0.299 | 0.079 | T cell inhibitor | 0.079 0.07 DBMET00163 | DBMET00163 | |
| 0.11 | 0.364 | 0.235 | Peptidyltransferase inhibitor | 0.235 0.062 DBMET00163 | DBMET00163 | |
| 0.01 | 0.312 | 0.046 | Mannosidase inhibitor | 0.046 0.031 DBMET00163 | DBMET00163 | |
| 0.013 | 0.323 | 0.059 | Alpha-mannosidase inhibitor | 0.059 0.028 DBMET00163 | DBMET00163 | |
| 0.092 | 0.417 | 0.387 | Sodium/bile acid cotransporter inhibitor | 0.387 0.021 DBMET00163 | DBMET00163 | |
| 0.079 | 0.404 | 0.28 | Gastrin inhibitor | 0.28 0.049 DBMET00163 | DBMET00163 | |
| 0.027 | 0.371 | 0.111 | Chelator | 0.111 0.063 DBMET00163 | DBMET00163 | |
| 0.015 | 0.363 | 0.069 | Nitric oxide donor | 0.069 0.034 DBMET00163 | DBMET00163 | |
| 0.012 | 0.365 | 0.044 | AICAR transformylase inhibitor | 0.044 0.03 DBMET00163 | DBMET00163 | |
| 0.036 | 0.412 | 0.153 | Interleukin 8 antagonist | 0.153 0.032 DBMET00163 | DBMET00163 | |
| 0.071 | 0.474 | 0.186 | Immunomodulator | 0.186 0.181 DBMET00163 | DBMET00163 | |
| 0.063 | 0.472 | 0.158 | Lipocortins synthesis antagonist | 0.158 0.094 DBMET00163 | DBMET00163 | |
| 0.019 | 0.445 | 0.101 | GABA C receptor antagonist | 0.101 0.076 DBMET00163 | DBMET00163 | |
| 0.037 | 0.48 | 0.171 | Nitric oxide antagonist | 0.171 0.081 DBMET00163 | DBMET00163 | |
| 0.007 | 0.739 | 0.421 | Neurotrophic factor | 0.421 0.005 DBMET01769 | DBMET01769 | |
| 0.009 | 0.902 | 0.198 | Nootropic | 0.198 0.16 DBMET00163 | DBMET00163 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |